Corner Therapeutics, Inc.

New Filing

CIK: 0002019875·Pharmaceuticals·DELAWARE·Filed: Apr 23, 2024

Total Offering

$50,941,210

Amount Sold

$50,941,210

Investors

14

First Sale

May 31, 2023

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2019
Non-Accredited Investors: No

Related Persons

Name	Role
Jonathan Kagan	Related Person
Andrew Bellinger	Related Person
Nick Seaver	Related Person
Steve Altschuler	Related Person
Alan Ezekowitz	Related Person
Jeffrey Karp	Related Person

Company

300 N. Beacon Street

Watertown, MA, 02472

617-701-7014

SEC Filing

0001567619-24-000263

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.